ProKidney enters $100M ATM equity offering agreement with Jefferies

PROKIDNEY CORP.

Agreement with Jefferies to sell up to $100M of Class A ordinary shares at the market.
Sales agent receives 3.0% of gross proceeds; company reimburses certain expenses.
No obligation to sell any shares; offering may be suspended at any time.
Sales made pursuant to effective shelf registration statement (filed Nov. 22, 2023).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.99

PROKIDNEY CORP. entered into Open Market Sale Agreement with Jefferies LLC valued at up to $100,000,000 (effective 2024-01-19).

Action: entry
Agreement: atm program
Counterparty: Jefferies LLC
Value: up to $100,000,000
Effective: 2024-01-19

Exact text from the filing

On January 19, 2024, ProKidney Corp. (the “Company”) entered into an Open Market Sale Agreement SM (the “Sales Agreement”) with Jefferies LLC (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time, shares (the “Shares”) of its Class A ordinary shares, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $100,000,000 through the Sales Agent, acting as agent.

View on SEC.gov

Browse all material agreements →

PROKIDNEY CORP. filing history →

Source: SEC EDGAR

accession 0001193125-24-011267

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.